Not an eMediNexus Member?
According to a randomized, placebo-controlled phase II trial, a novel insulin formulation administered once weekly appeared to b ...MORE
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion f ...MORE
The Food and Drug Administration has approved a triple-combination tablet (Trijardy XR), comprising empagliflozin, linagliptin, ...MORE
There was no difference between human and analogue insulin in terms of cardiovascular and mortality outcomes, but cost is anothe ...MORE
Scientists have developed a new form of insulin that could improve the clinical delivery of the drug for people living with diab ...MORE
Rapid-acting insulin analogues are found to be more effective at reducing postprandial glucose and improving HbA1c than regular ...MORE